CLAIM CARD
A significant within-corpus tension exists regarding aspirin's net benefit profile. While several analyses report null findings for aspirin-based regimens compared to alternatives in specific endpoints (Saeed 2026; Stirum 2026; Hou 2026), other data suggest potential harm. For instance, a study on pregnant individuals with increased heat exposure demonstrated that aspirin use was associated with a negative effect direction on preterm birth risk, presenting a potential adverse pathway that could counter any theoretical geroprotective benefits in susceptible subpopulations (Meltzer 2026). This disagreement underscores that the overall risk-benefit calculus for aspirin as a geroprotector is not straightforward and may be modulated by environmental and individual risk factors not typically considered in aging research.
Evidence grade: exploratory
Contradiction status: none
Publication: 4ff5f065-8b09-4580-9cbc-da14dbcaa1fa
Provenance: Derivation Web chain
Citation Support
source_1Flensted-Jensen 2025source_2Saeed 2026source_3Zhu 2026source_4Navarese 2026source_5Yan 2024